Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0280976 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Mathilde Pacault und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Génétique Moléculaire et Histocompatibilité, Brest, France. Hauptthemen laut MEDLINE: Noninvasive Prenatal Testing, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFM-Téléthon, Association Vaincre la Mucoviscidose, Agence de la Biomédecine.
Abstract (Originalsprache)
Non-invasive prenatal diagnosis of single-gene disorders (SGD-NIPD) has been widely accepted, but is mostly limited to the exclusion of either paternal or de novo mutations. Indeed, it is still difficult to infer the inheritance of the maternal allele from cell-free DNA (cfDNA) analysis. Based on the study of maternal haplotype imbalance in cfDNA, relative haplotype dosage (RHDO) was developed to address this challenge. Although RHDO has been shown to be reliable, robust control of statistical error and explicit delineation of critical parameters for assessing the quality of the analysis have not been fully addressed. We present here a universal and adaptable enhanced-RHDO (eRHDO) procedure through an automated bioinformatics pipeline with a didactic visualization of the results, aiming to be applied for any SGD-NIPD in routine care. A training cohort of 43 families carrying CFTR , NF1 , DMD , or F8 mutations allowed the characterization and optimal setting of several adjustable data variables, such as minimum sequencing depth, type 1 and type 2 statistical errors, as well as the quality assessment of intermediate steps and final results by block score and concordance score. Validation was successfully performed on a test cohort of 56 pregnancies. Finally, computer simulations were used to estimate the effect of fetal-fraction, sequencing depth and number of informative SNPs on the quality of results. Our workflow proved to be robust, as we obtained conclusive and correctly inferred fetal genotypes in 94.9% of cases, with no false-negative or false-positive results. By standardizing data generation and analysis, we fully describe a turnkey protocol for laboratories wishing to offer eRHDO-based non-invasive prenatal diagnosis for single-gene disorders as an alternative to conventional prenatal diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratoire de Génétique Moléculaire et Histocompatibilité, Brest, France.
- Service de Médecine Génomique des maladies de système et d'organe, APHP.Centre - Université Paris Cité, Hôpital Cochin, Paris, France.
- Université de Paris, CNRS, MAP5 UMR8145, Paris, France.
- MOABI, Plateforme bio-informatique AP-HP, Département I&D, DSI, Paris, France.
ORCID-Profile: Mathilde Pacault, Camille Verebi, Juliette Nectoux
Förderung
- AFM-Téléthon
- Association Vaincre la Mucoviscidose
- Agence de la Biomédecine
- Agence Gaétan Saleun
Zitieren
APA
Pacault, M., Verebi, C., Champion, M., Orhant, L., Perrier, A., Girodon, E., Leturcq, F., Vidaud, D., Férec, C., Bienvenu, T., Daveau, R., & Nectoux, J. (2023). Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation. PLOS ONE. https://doi.org/10.1371/journal.pone.0280976
Vancouver
Pacault M, Verebi C, Champion M, Orhant L, Perrier A, Girodon E, et al. Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation. PLOS ONE. 2023. doi:10.1371/journal.pone.0280976
BibTeX
@article{Pacault2023,
author = {Pacault, Mathilde and Verebi, Camille and Champion, Magali and Orhant, Lucie and Perrier, Alexandre and Girodon, Emmanuelle and Leturcq, France and Vidaud, Dominique and Férec, Claude and Bienvenu, Thierry and Daveau, Romain and Nectoux, Juliette},
title = {Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0280976}
}
EUVIMED